Abstract:
Aspects described herein relate to stable cell line for recombinant viral vector (e.g., recombinant adeno associated viral vector) production comprising at least one inducible promoter operatively linked to a heterologous gene that encodes a toxic protein. Methods for making stable cell lines, and methods for viral vector production are further provided herein.
Abstract:
A method and apparatus for producing crystalline protein particles. A protein solution is re-circulated from a reservoir container (1) using a pump (2), through one or more capillaries (3) and back to the reservoir (1) through a re-circulation loop (5) and an outlet (6). In the capillary zone the solution is treated such that the protein solubility decreases, causing the protein to precipitate.
Abstract:
The invention relates to a method for transmission mode change in a telecommunication network, said network having a public network comprising at least one public base station (NB) covering a public cell and a private network comprising at least one private base station (PBS) covering a private cell, wherein said at least one private base station has limited access rights for User Equipment (UE:s) in the private network, and where said UE:s are able to also communicate with the public network, comprising the step of: performing a private base station transmission mode change when the private base station is in an interference reduction transmission mode to an active transmission mode when an UE with access rights to said private base station is detected in proximity of said private base station, where a detection of said proximity is based on information being specific for said UE and its relation to said private base station. The invention also relates to a telecommunication network.
Abstract:
A hand held electronic device, such as a flash memory drive, includes a mechanism for extending and withdrawing a connector, such as a USB plug, that is adapted for engaging a mating connector of a host device. A positive latch holds the connector with respect to an outer shell when in the extended and withdrawn positions. Movement of a separate housing portion unlatches the connector and outer shell, and also provides movement of the connector. A protective door closes over a connector opening when the connector is withdrawn into the device, and the door is withdrawn into the device when the connector is extended, thereby not interfering with the extended connector.
Abstract:
A transmitting method in a wireless communication system includes: assembling a plurality of first data units into a second data unit on a data channel, each of the plurality of first data units being destined for a corresponding one of a plurality of receivers respectively; allocating a plurality of first control channels, each of the plurality of first control channels corresponding to one of the plurality of receivers respectively, and including an identity of the corresponding receiver; transmitting each of the p rlurality of first control channels; and transmitting the second data unit through the data channel, association information between each of the plurality of first data units and the corresponding receiver is carried by the corresponding first control channel or by the second data unit so as to allow each of the plurality of receivers to extract the corresponding first data unit from the second data unit. Also, a receiving method, a transmitter and a receiver in the wireless communication system are provided correspondingly.
Abstract:
The present invention is directed to antifolate compounds having the structure of formula (I). wherein: X is CHR9 or NR9; Y1, Y2, and Y3 independently are O or S; V1 and V2 independently are O, S, or NZ; Z is H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, or alkaryl; R1 and R2 independently are H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, or alkaryl; R3 is H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy, hydroxyl, or halo; and R4, R5, R6, R7, Rs, and R9 independently are H, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, acyl, -C(O)-alkyl, - C(O)-alkenyl, or -C(O)-alkynyl; as well as pharmaceutically acceptable esters, amides, salts, solvates, and prodrugs thereof. The compounds are useful in pharmaceutical compositions and in methods of treating multiple conditions, including abnormal cell proliferation, inflammatory diseases, asthma, and arthritis.
Abstract translation:本发明涉及具有式(I)结构的抗叶酸化合物。 其中:X是CHR 9或NR 9; Y1,Y2和Y3独立地为O或S; V1和V2独立为O,S或NZ; Z是H,任选取代的烷基,任选取代的烯基,任选取代的炔基或烷芳基; R 1和R 2独立地为H,任选取代的烷基,任选取代的烯基,任选取代的炔基或烷芳基; R 3是H,任选取代的烷基,任选取代的烯基,任选取代的炔基,任选取代的烷氧基,羟基或卤素; R 4,R 5,R 6,R 7,R 5和R 9独立地为H,任选取代的烷基,任选取代的烯基,任选取代的炔基,酰基,-C(O) - 烷基,-C(O) - 烯基或-C (O) - 炔基; 以及其药学上可接受的酯,酰胺,盐,溶剂合物和前药。 该化合物可用于药物组合物和治疗多种病症的方法,包括异常细胞增殖,炎性疾病,哮喘和关节炎。
Abstract:
The invention relates to a method in connection with a multimedia service transmission over a terrestrial wireless network, wherein the multimedia service transmission is sent from a wireless transmitter to at least one single receiver/transmitter user equipment, comprising the steps of: creating in said single receiver/transmitter user equipment, information relevant for said wireless multimedia service transmission, and feeding back said information to a network entity by using a different communications means separate from said terrestrial wireless network, so as to allow an adjustment of the multimedia service transmission in respect of said information, and where the process of feeding back said information is controlled by a network entity. The invention also relates to an user equipment and a network entity.
Abstract:
An internal component arrangement within a battery pack housing having multiple cells and adapted for cordless power tools may provide desired mechanical support to constrain the cells. The housing with internal component arrangement is configured to route sensing wires from the cells to an electronics module of the pack.
Abstract:
Cells that are deficient in TNF responsiveness are susceptible to infection with a myxoma virus. People infected with myxoma virus infection are treated using an activator of tumor necrosis factor receptor. MT-2 deficient myxoma viruses are useful in treating cancer.
Abstract:
The present invention provides for a method of controlling selection of a localised scheduling scheme or a distributed scheduling scheme within an OFDMA downlink and including the step of estimating a fading characteristic and initiating switching between the scheduling schemes responsive to the result of the said estimation, wherein the fading characteristic can comprise one of fading rate or fading type, and wherein the invention can provide for such estimating functionality within a mobile radio communications device.